Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension

被引：20
|
作者：
Anthi, Anastasia [1 ,2 ]
Tsangaris, Iraklis [1 ,2 ]
Hamodraka, Eftichia S. [3 ]
Lekakis, John [2 ,3 ]
Armaganidis, Apostolos [1 ,2 ]
Orfanos, Stylianos E. [1 ,2 ]
机构：
[1] Univ Athens, Sch Med, Dept Crit Care 2, Attikon Gen Hosp, GR-11527 Athens, Greece
[2] Univ Athens, Sch Med, Pulm Hypertens Clin, Attikon Gen Hosp, GR-11527 Athens, Greece
[3] Univ Athens, Sch Med, Dept Cardiol 2, Attikon Gen Hosp, GR-11527 Athens, Greece
来源：
BLOOD | 2012年 / 120卷 / 07期
关键词：
SICKLE-CELL-DISEASE; SILDENAFIL;
D O I：
10.1182/blood-2012-04-422568
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1531 / 1532
页数：4
相关论文
共 50 条
  • [31] Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects
    Sitbon, O.
    Beghetti, M.
    Petit, J.
    Iserin, L.
    Humbert, M.
    Gressin, V.
    Simonneau, G.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 : 25 - 31
  • [32] Long-term bosentan treatment in children with pulmonary arterial hypertension
    Standing, JF
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (09) : 1914 - 1915
  • [33] Pharmacoeconomic evidence of bosentan for pulmonary arterial hypertension
    Strange, Geoff
    Keogh, Anne
    Dalton, Brad
    Gabbay, Eli
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2011, 11 (03) : 253 - 263
  • [34] The bosentan patient registry: long-term survival in pulmonary arterial hypertension
    Keogh, A.
    Strange, G.
    McNeil, K.
    Williams, T. J.
    Gabbay, E.
    Proudman, S.
    Weintraub, R. G.
    Wlodarczyk, J.
    Dalton, B.
    [J]. INTERNAL MEDICINE JOURNAL, 2011, 41 (03) : 227 - 234
  • [35] Bosentan combined with sildenafil in the treatment of COPD patients with pulmonary arterial hypertension
    Li, Ying
    Wang, Yao
    Liu, Shaohua
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (10): : 11522 - 11530
  • [36] ADVERSE EFFECTS OF BOSENTAN IN PATIENT WITH SSc-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION
    Egashira, S.
    Makino, T.
    Jinnin, M.
    Ihn, H.
    [J]. RHEUMATOLOGY, 2012, 51 : 99 - 100
  • [37] Edema in Patient Switched to Macitentan from Bosentan and Ambrisentan in Pulmonary Arterial Hypertension
    Safdar, Zeenat
    Thakur, Aishwarya
    Frost, Adaani
    [J]. CHEST, 2015, 148 (04)
  • [38] Risk factors for pulmonary hypertension in patients with β thalassemia intermedia
    Karimi, Mehran
    Musallam, Khaled M.
    Cappellini, Maria Domenica
    Daar, Shahina
    El-Beshlawy, Amal
    Belhoul, Khawla
    Saned, Mohamed-SalahEldin
    Temraz, Sally
    Koussa, Suzanne
    Taher, Ali T.
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2011, 22 (06) : 607 - 610
  • [39] Risk factors for pulmonary hypertension in patients with thalassemia intermedia
    Amoozgar, Hamid
    Farhani, Nahal
    Karimi, Mehran
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (06) : 549 - 551
  • [40] Bosentan in Pediatric Patients with Pulmonary Arterial Hypertension
    Beghetti, Maurice
    [J]. CURRENT VASCULAR PHARMACOLOGY, 2009, 7 (02) : 225 - 233
12345